79 studies found for:    "Kidney Diseases, Cystic"
Show Display Options
Download search resultsDownload the search results for:
"Kidney Diseases, Cystic" (79 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
2 Unknown  UAB Recessive PKD Research and Translational Core Center
Condition: Autosomal Recessive Polycystic Kidney Disease
Intervention:
3 Completed Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: pravastatin;   Drug: Placebo
4 Completed Assessment of the Prevalence of Genes AHI1, NPHP1 and CEP290 in Joubert Syndrome
Conditions: Joubert Syndrome;   Cerebello-oculo-renal Syndromes
Intervention: Biological: Whole blood sample
5 Recruiting Contrast-enhanced Ultrasound for the Evaluation of Complex Renal Cysts
Condition: Complex Renal Cyst
Intervention: Procedure: Contrast-enhanced ultrasound
6 Recruiting Clinical and Molecular Investigations Into Ciliopathies
Conditions: Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
Intervention:
7 Recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
8 Recruiting Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
9 Recruiting Transplant Patient Registry of Liver, Kidney and/or Pancreas
Conditions: Hepatitis B;   Hepatitis C;   Liver Cirrhosis;   Hepatocellular Carcinoma;   Polycystic Kidney Diseases
Intervention:
10 Unknown  Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
Condition: Kidney, Polycystic, Autosomal Dominant
Interventions: Drug: Cilnidipine;   Drug: Imidapril
11 Recruiting Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease
Conditions: Polycystic Kidney, Type 1 Autosomal Dominant Disease;   Polycystic Kidney, Type 2 Autosomal Dominant Disease
Interventions: Drug: Sirolimus;   Drug: Placebo
12 Recruiting Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells
13 Completed Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Other: Water prescription
14 Active, not recruiting Bosutinib For Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Bosutinib;   Drug: Placebo
15 Completed The Vienna RAP Pilot Study
Condition: ADPKD
Intervention: Drug: Sirolimus
16 Terminated The Relation Between Uric Acid Level and Endothelial Dysfunction in Patients With Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Intervention:
17 Completed Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)
Condition: Polycystic Liver Disease
Intervention: Drug: Lanreotide
18 Completed Effects of Somatostatin on ADPKD Heart
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Glomerular Filtration Rate > 40 ml/Min
Interventions: Drug: Octeotride;   Drug: Placebo
19 Recruiting Sirolimus for Massive Polycystic Liver
Condition: Polycystic Kidney Diseases
Intervention: Drug: Sirolimus
20 Recruiting Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Hypertension
Interventions: Procedure: renal sympathetic denervation;   Drug: antihypertensive drugs

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years